Grifols, S.A. ( GRFS) - Key Metrics
GRFS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.88 | $0.14 | ? | ? |
| 2025Q3 | $2.74 | $0.19 | $0.48 | $0.38 |
| 2025Q2 | $2.75 | $0.17 | $0.23 | $0.14 |
| 2025Q1 | $2.62 | $0.09 | $0.20 | $0.13 |
GRFS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 18.75 |
| 2025Q3 | 80.64% | 16.52 |
| 2025Q2 | ? | 15.22 |
| 2025Q1 | ? | 23.35 |
GRFS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.25% | ? |
| 2025Q4 | 6.19% | ? |
| 2025Q3 | 4.42% | 1.22% |
| 2025Q2 | 1.80% | ? |
| 2025Q1 | 1.93% | ? |
GRFS
Price: $7.58
52 week price:
Dividend Yield: 2.41%
Payout Ratio Range:
Dividend Per Share: 0.18 USD
Earnings Per Share: 0.70 USD
P/E Ratio: 11.14
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Spain
Volume: 924384
Ebitda: 362.6 millionMarket Capitalization: 6.3 billion